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Expression of basic fibroblast growth factor cDNA or 
dominantly acting oncogenes, e .g. , EtA, in immor-
talized mouse melanocytes leads to autononlOUS 
growth i1l '';(''0, depigmentation, and in the case of the 
oncogenes, tumorigenesis. Because downregulation 
of pigmcntation is a conlmon event in hUlnan Ineta-
static mclanonla cells grown in culture, we deter-
lllined the molecular basis of depignlentation in a 
mouse nlelanocyte Inodel system. We tested the 
effect of EtA mutants deficient in their ability to 
neutralize several regulatory proteins and deter-
mined changes in lUelanogenic gene expression. We 
identified Microphthalmia as the affected, downregu-
lated transcription factor in melanocytes rendered 
amelanotic by E1A, basic fibroblast growth factor, or 
the oncogenes ms or lieu., and in an amelanotic cell 
variant of CloudIUan S9t mouse melanoma. Against 
expectations, sequestration of p300, a transcriptional 
T he pigmented dendri tic ph enotype of m elanocytes is often lost w hen growth-regulato ry m o lecules are abe rrant1 y expressed, conferring independence from externa l g rowth f.,cto rs. Exa mples arc m elanocytes express in g basic fibrob last gro wth facto r (bFG F) or 
the dominantly actin g o ncogene products ras, ",ye, adenovirus E 1 A, 
polyolTla middle T anti ge n, o r SV40 large T antigen (Doo ley cl ai, 
1988; Dotto el til , 1989; Jambrosic et til , 1989; Wil son et ti l, 1989; 
Larue el til, 1993). Likewise, SV40 transgenic mice that express 
simi an virus 40 gen es specifi caUy in m elanocytes via the tyros inase 
promoter arc hypo pigme nted, possib ly as a result of dowm-egul a-
tion of severa l m elanocyte-specific proteins (Brad l cl ai, 1991 ; 
O rl ow el ti l, 1995). III Il il ro, such m elanocytes arc not o nl y 
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Abbrev iatio ns: bFGF. basic fibrob last growth fa ctor; bHLHl.Z. basic 
he li x-loop-he li x le ucine zipper; C UI'. CR.E13- binding protein; CR.E13 , 
cyclic adenosine ll1 o nophosphate-respo nsive cle ment binding protein; Mi, 
microphthalmia ; PED. pink-eyed d ilu tion ; R.h. retinoblastoma gene prod-
uct; T PA.1 2-0-tetradecanoyl-phorhol- 13-acetate; TR.l'l ilnd TR.1'2 . ty-
rosinase-related prote ins I (/mll, ,"-l ocus prowin) and 2 (slaty- locus protein). 
adaptor that Inediates responscs to cyclic adenosine 
monophosphate, was not required for the full trans-
forlUing effects of EtA. Our results suggest that in. 
addition to controlling tyrosinase (albino locus) and 
tyrosinase-related protein t (TRPt/gp7S/brown lo-
cus), both known to possess the DNA consensus site 
for binding the Microphthalmia protein, this tran-
scription factor also controls other luelanocyte-spe-
cific genes such as pink-eyed dilution and Plllel t7 
(silver), but not tyrosinase-related protein 2 (slaty 
locus). Furthermore, these findings show that mi-
cy()pi,tira.lmia is downregulated not only by experinten-
tally introduced dominantly acting oncogenes but 
also by the aberrant expression of basic fibroblast 
growth factor and by spontaneous tUlnorigenic trans-
formation. Key 1V0/'ds: "asic FGF/FGF2/domill,alltly actil/g 
0I/CCJgeues/E1A/p300. J Izlllest Dem,a(ol 106:1266-1272, 
1996 
amelanotic, they arc a lso adendritic and fibro blastoid in shape. 
In fection of imm ortal m o use m e lanocytes with a retro viral vector 
carrying E1 A was shown to downregulate murine microphthalmia 
(Mi) (Ya vuzer 1'1 ti l, '1995) , a gene en codin g a transcription factor 
that binds to an 11-bp domain known as the M-box in the 
tyros ill ase- alld ty rosinase-re la ted prote in-1 (T IU)l) enhancer re_ 
g ions (Bentley 1'1 ti l, 1994; I-Iem esa th 1:1 ai, 1994; Yasumoto er til , 
1994). 
T he transform ill g ability of the aden ov iru s E1 A 12S and 'I 3S gen e 
pro du cts res ides mainl y in the short N-terminal do main and two 
conserved regio ns designated C R..1 (amino ac ids 40-80) and CR2 
(amin o acids 121-1 39) (fo r reviews, sec Peepe r and Zantem a, 1993 ; 
Dyson , 1994). Several proteins implicated in the control of cel] 
cycle progress ion and tran scrip tional activi ty arc n eu tra lized by 
binding to these regions. Among them arc the pl 05 retin oblastol11<1 
(R.b) susceptibili ty gene produc t, the two retin o bla stoma-related 
pro teins pl07 and p1 30 , as well as p60")'cnn A, the cell cycle kinase 
p33 c dk2 , and a prote in of300 kDa known as p300 (Tsai el ti l, 1991; 
Cobrinik el ai, 1993; Fattaey 1'1 a i , 1993 ; Li el ti l, 1993 ; Eckner 1'1 ai, 
1994); p300 binds to the protein kinase A-phospho ryla ted form of 
the cycli c aden osin e m o nophosphate (cA M P) responsive element 
bindin g protein (C REB, a transcription fac tor) and thus can 
m ediate cellular respo nses to cA MP (Lu ndbl ad ct til , 1995). Because 
C lUB is ac ti vated in norm al hum an melan ocytes by syne rgistic 
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Table I. E1A-Encoding Plasntids and Their Protein-
Binding Specificities" 
Specifi c Protein-Binding Ability 
E1A Deleted 
Derivative Amino Acids 1'60 1'105 pt07 1'300 
NTd1814 2-85 + 
d1922 /947 122-1 29 + 
NTd1598 2- 13 + + + 
dl799N B1-85 + + + + 
01 T he E t A dc ri vari v~s and the hinding specificity of the encoded proteins are as 
described in Mi ssero CI III (199 1) . 
groW'th factors, among them bFGF (Bohm cl nl, 1995), we inves-
tigated whcther scquestration of p300 was the basis for the dedif-
ferentiation and tumorigenicity o f E1A- transfonned mouse mcla-
nocytes . We found that expression of an E 1 A mutant protein that 
does not bind p300 n everthe less conferred the comple te tumori-
genic phenotype on melanocytes and that r ed uction in m c lanocyte-
specific functions was associated with downregulation of III; and 
concorn.itantly the gen es for tyrosinase , tyrosinase-related prote in 1 
(TRPl/gp75/brown-locus protein), p ink-eyed dilution protein 
(PED), and Pmel 17 (a 5,6-dihydroxyindole-2-carboxylic acid 
converting factor) (Chakraborty el nl, 1996; Lce el nl, 1 996) but not 
TRP2 (thc slaty locus protein, dopac hrome tautomerase) . Suppres-
sion of III; was observed also in melanocytes dediffe rentiated as a 
result of expression of bFGF cDNA cloned in mammalian expres-
sion vector, or through transfonnat1on b y ras or 1/el1, and i.n an 
amelanotic cell variant of the spontaneously originate d murine 
C loudman S91 mclanoma but not an amelanotic B 1 6- m c la noma 
cell line. 
MATER.lALS AND METHODS 
Cells and Culture Conditions, Transfectioll, and Proliferation/ 
Tumorigenicity Assays The parental BtO .BR mouse melanocyte line 
was Inaintaincd in ,Ham's FlO mcdium supplemcnted with 200 U / ml 
perucilllll, 100 /Lg/ml streptomycin (Gibco Laboratories. G rand Island. 
NY), and 10'Y" horse serum, plus 85 nM 12-0- tctradecanoyl-phorbol-13-
ace ta te (TPA) (Sigma. St . Louis , MO) (Tamura e ( ai, 1987). This melano-
cyte line had lost its requ irement for cyclic adenosinc m onophosphate 
supplen-.entation spo ntancously (Dotto ", ai, 1988) . Basic FGF-. 1'0$-. and 
lIell-transformcd Bl0.liR me lanocytes (Dotto el nl. 19B8), NIH 3T3 murinc 
fib roblasts, and amelanotic C loudman S91 and B 16 murine melanoma cc lls, 
however, were Inaintolincd in the above 111Cdiulll \"vithout T PA. 
T he threc El A deletion mutants, NTdI 8 '14, dl922 /94 7, and NTd1598, 
that vvere used to tra nsfect murinc melanocytes, as well as wild-type 
d1799 N , wcre as described (Misscro {!/ ai , 199'1} and are delincated in Table 
l. In the fig ures, dl92 21947 is rcfcl:rcd to as dl922. The recombinant 
plasnlids also encode th e neomycin resistance gene to f;lcilitatc the selection 
of tra nsduced ce lls. Wherevcr call ed for in the text, the abil ity of the 
respective mntants to bind cc rtain regulatory proteins is indicated by a plus 
(+ ) or a minus ( - ) sign nex t to the size designatio n of the respective 
proteins. Approximately 1 X 10" BI0.BR melanocyte. at passages 20 - 25 
wer e transfccted with plasmid DNA (10 JJ.g or 20 JJ.g/ plate) , using the 
Jipofec tion reagent DOTAP (Boehringe r, Mannheim. Germany) according 
to the manufacturer 's instructions. The pSVneo m ammalian expression 
vecto r (Biotech Research Laboratories . Rockville, MD) alo ne served as a 
nega tive contro l. Approx.imately 20 clones for each transfection were 
isola t e d after 3-5 wk of selection in medium supplemented with neomycin 
(G418, 800 JJ.g/ml) plus TPA. For each casc, three to four clones were 
expanded and analyzed . The slash / numerica l designations in the fi gures 
refe r to the respective cloned transfcctant ce ll lines . 
For proliferation assays, cells were seeded in 12-wcll cluster plates 
(- 3000 cells/cm2) and grown in sets of dupli ca te wells in basic medium 
with or without the following add itions: n eomycin (G418). TPA , o r both. 
Media ~ere renewed every 3 d. and cell s from each o f the dupli cate wells 
were counted in a Coulter coullter. Populatioll doubling times were 
calculated fioln the slopes of the linear portions of the growth curves . 
To assess tumorigenicity, cell s were injected subcutaneonsly (1 X 10" 
cells/injection site) in to 4- to 6-wk- o ld syngene ic (B 'I O.BR) or nude .. nice 
(Th e Jackson Laboratory , Bar Harbor. ME), four mice/cell type. T he mice 
were inspected weekly for tumor growth over a period of 3 mo. 
R.EPRESSION OF Ml IN TRANS FO RM ED MELANOCYTES 1267 
Western Il11l11LJnoblotting, Tyrosinase Activity, and Ultrastructure 
To determine the levd s of El A- and m elanocyte-specifi c proteins, cclls 
were detached from the culture surfacc, washed in phosphate-bufFe red 
saline. and lysed in buffer comaining 20 mM p-nitrophenyl phosphate. 20 
mM Tris-H C I, pH 7.5, 1 mM e th yleneglyco l-bis(/3-al11inoethyl ether)-
N,N,N' .N' -tetraace tic acid, J 0 mM MgCI2. 50 111M sod iulll flu oride . 5 mM 
bcn z<1 rnidinc, and 1 (XI Nonidc t P-40. Prote in con tent \~r as dc ternlincd w ith 
the J3 io-Rad reagent kit (B io-Rad Laboratories. H ercul es , CAl. and com-
parable amounts (- 60 JJ.g/lane) were fractionated in 8% po lyacrylamide 
mini-gels. T he fra ctio nated proteins wcre tra nsferred to po lyvinylide ne 
difluoride protein-sequencing m embranes (B io-Rad Laboratories) and sub-
j ected to a successio n of itnnlllllo b1 o ttings. first w ith and-E IA 111 o nocio llal 
antibod y M73 (Harlow rl ai, 1986) (prodnced by us fi'om thc hybridoma 
clone) . followcd by anti-tyros inase alltibodics (Ha laban et ai, '1983), the 
rabbit anri- b-Iocll s protein / TRl'l an tiserum known as a PEP1 (from Dr. V. 
J. H earing. Na tional Cancer [nstitute, Bethcsda, MD). and rabbit po lyclo nal 
anti-PInel 17 antibodics (aPmel 17N; Kwon e( al. 1994) (fi'ol11 Dr. B. S. 
Kwon . Indiana Uni versity School of Medicinc, Illdianapo lis, IN). Irnmu-
noblotting with rabbit anti-TRP2 an tiserum known as a P EPB (Tsukamoto 
el al. '1992) (fi'om Dr. V. J. Hearing) was performed on proteins immobili zed 
to a fre sh membrane. In the case ofbFGF-transduced m clanocytes, we used 
antibodies ro tyrosinase . T R]>] , T IU>2. and PED (R osemblat cl al. 1994) 
(fro m Dr. Seth Orlow, New York Unive rsity School of Medicine. N ew 
York, NY). Between blottings, the melllbranes were stripped ofF the 
preceding antibodies by incubatio n in n solu tio n containing 7 M guanidine 
hydroc hloride, 50 mM glycine. pH 10 .B. 0 .05 mM eth ylenedi amine te t-
raacetic acid , 0. 1 M KC!. and 20 mM 2-mercaptoethano l at room temper-
ature for 10 tHin 0 11 a shaking platfornl . T hey we re th en rinscd thoro ughl y . 
and nonspecifi c binding sires were blocked fo r 1 h o r overnight with 10% 
bovine se rum albumin before application o f rhe nexr antibody. Monoclonal 
anti-E I A antibody was used at 1 JJ.g / ml ; polyclonal antibodies or antiserum 
was used at dilutio n 1:1000 in 5% BSA and 10 111M each ofTris-H C I buffc r 
pH 8, and NaC!. plus 0.2% Tween-20. Bound antjbodies were detected b; 
cnhnl'lced che lllilutnincsccncc (AnlcrshaI11 , Arling ton ]-) c ig h ts, IL) , accord-
ing to the manuf:lc turer's instructions . Immunoprecipitates ofEl A products 
were prepared from cells Iyscd in low-sa lt buffe r as described (Harlow el ai, 
1986) . 
Tyrosinase activity was Ineasl1fcd in cell ex tra cts contain ing 50-200 J.Lg 
protein / assay (Dotto '" al. 1989). One unit of tyrosinase is defincd as the 
am ount of enzym e that ca talyzed the ox idation of 1 mM of tyrosine in 1 
111ill. 
For electron rnicroscopy, ce ll pellets were fi"l!d with Karnovsky's 
formaldehyde-glut'1ra ldehydl! fixati ve and processed as described (Ootto c( 
ai, 1988) . Ultrathin sections w ere stained with "queous uranyl ace tate and 
lead citrate. 
Identification of Melanocyte-Specific mRNAs \-'(Ie nsed reverse 
transcription polymerasc chain reaction (RT -PCR) to determ ine the ex-
pression of mRNAs of several melanocyte-specific ge nes rela tive to /3-actin 
mRNA. Primer pairs (- 22 m er each). synthesized b), the Ya lc o ligonucle-
otide synthes is core fac ility , were selec ted fo r the nmplifi c<ltion o f products 
of 400- 600 bp. based On sequen ces of the respl!ctivc murine genes. except 
fo r human /3-actin (Table II). T ora l RNA was ex trncted w ith 4 M 
guanidine thiocyanate, fo llowed b), phenol-chloroform exn'action and 
ethano l precipitation . RNA (5-10 JJ.g) W'1S first annealed wi th the down-
streanl anti-sense printe r and th c n reve rse-trallscribed with 200 U reverse 
trallScriptasc (SuperScript RT, G ibcoBlU) for 1 h a t 37°C. fo llowed by 
amplifi cation fo r 25 cycles in the prcsence o f 50 I'M of sense and anti sense 
pril1lcrs with 20 U of AlI1pli- T aq polymerase (Pe rkin-Elmer. N o rwa lk, CT) . 
Amplifi cation was carri ed Oll t for I min at 95°C . I lI1in at 50°C , and I min 
a t 72°C. To confirm that the ampliJication proceeded exponen tially . 
aliquots were removed after 25 . 28. and 31 cycles. T he reaction products 
were c lcctrophorcsccl 0 11 a 2ty;, 'lgarosc ge l. sta ined w"ith cthi diuI11 br01l1idc, 
and visuali zed with ultravio let light. 
To substantiate that Our PC R prodncts corrc sponded to th e il1tcndcd 
scgmcl1ts of targeted cDNA. amplifi ed fi'agl11 el1ts fi'om o nl y the control 
pSVneo-transfected cdls were purified and sequenced b y the DNA se-
quencing service at the Boye r Center fo r M olecular Medicin e. Yale 
University School of Medicinc. 
RESULTS 
Downregulatiol1 of Pigmentation Correlates with Autol1o-
ntous Growth Transfection w ith each of the E1A plasm ids 
d escribe d in Table I yie lded - 20 clones of stablc tra nsfectants 
selecte d in m edium supple m e nted with G418 as well as TPA (to 
e n sure the growth of transduced cell s that remain ed d e p e nde nt on 
growth factors). As shown in Fig 1A and B, all NTdl598 (p60 + , 
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Table II. Primers used in RT-PCR" 
Gene l Accession Number 
MUSTYR/000 131 
MMTYR/ X03687 
Silvcr/MMU14 1 33 
M .USPEDGOR/M97900 
MMTYR.P2/X63349 
M .MMrBI-ILI-I/Z23066 
human !3-actin/X00351, J00074 
lTIouse G3POH/M32599 
MMCIGTM/X65997 
MMMETONC/y00671 
Gene Product 
Tyrosinase 
TR]>l 
Pmcl17 
Pink-eyed di lu tion 
TRP2 
Mi 
!3-actin 
G3POI-I 
KIT 
MET 
Primer (F, fo rward; 13, backwa rd) 
F(158-177): 5'GCAAAAGAATGCTGCCCACC3' 
13(657-635): 5'ATGTCCCTCCATATTTCAGAGCC3 ' 
1'(269-292): 5' ATATTGAGGCTCTGAGACGTGGGG3' 
13(669-646): 5'CCTCCTTGTGGCAATGA AAATTG3' 
F(69-92): 5' ATCCAGGAATCAGGACTGGCTTGG3' 
13(6 12-592): 5'TGAAGGTTGAACTGGCGTGAG3' 
F( 101-·124): 5'CGAGTCATCAGACAGATCAGCAAC3' 
13(569-547): 5'CCAATGCAGACAAATCAGCAACC3' 
F(82-IOS): 5'GAGAAGCTCCCCTCATTAAACCTG3' 
B(5l4 - 491): 5'TTCAGCACGCCATCCAAGGTCATG3 ' 
1'(115-1 36): S'GCCTGAAACCTTGCTATGCTGG3' 
13(577-536): 5'CGGGTAACGTATTTGCCATTTG3' 
F(144-155): 5'GTGGGGCGCCCCAGGCACCA3' 
D(682-672): 5'CTCCTTAATGTCACGCACGATTTC3' 
F(501-524): 5'CCAACTGCn"AGCCCCCCTGGCCAAG3 ' 
13( 1045-1021): CTCCTTGGAGGCCATGTAGGCCA'TG3' 
F(398-41 9): 5'CTCGGAGAGCTGAAATGAATGG3' 
13(854 -833): 5'GGACAACCTGCTTGAATGTTGG3 ' 
F(6S ·1-671): 5'GCTGAAGGAAACCCAAGATGG3' 
13(1060-1039): 5'CAGCAGAATCTGGCTTGCTTTG3' 
Size 
500 
401 
54-1 
469 
-1 33 
463 
540 
545 
457 
-110 
~. Sequences arc as deposited in the National Center for Biotech no logy Inform ation data hase LInde r d lC given accession lIumber. Nu m bers in pnrcl1ril cs is indi cate rhe Ilucleotide 
position \v ithin each sequen ce. Size denotes tile Ill11l1bcr of base p<lirs of the ItT-PC R product . 
pI 05 + , plOT'· , p300 - ) transfectants appeared morphologica lly 
transformed and unpi gmented; dl799N (p60 +, pl 05 + , pl07 + , 
p300+) transfectants were cither no rm ally pigmented o r they 
displayed the unpigmented phenotype. [n contrast, a ll NTdl814 
(p60- , pl05 - , pl07 , p300 - ) and dl922/947 (p60 - , pl0s - , 
pl07- , p300 +) transfec tants werc morphologica lly no rmal and 
pigmen ted . The norm ally pigmented transfectants were indisti n-
guishable fi·om one another, from clones transduced with the 
pSVneo control plasmid, and from normal untransfected melano-
cytes . 
All morphologically normal pigmented G418-rcsistant c1oncs, 
regardless of genotype, expressed melanosomes stages III-IV (Fig 
1 C, a) and premelanosomes. [n contrast, the amelanotic, fibrob las-
toid , or epithe lio id transfectants expressing NTd ls98 (p60 +, 
pl05 "', plOT'· , p300 - ) o r dl799N (p60 + , pl05 + , plOTI- , p300 +) 
constructs did not possess identifiab le melanosomes of any stage. 
Only ill-defined primal)' lysosome-like gran ules and vcsiclcs were 
seen in the trans-Golgi regions (Fig le, b). 
Like their parental counte rparts and the pSVneo contro l trans-
fecta nts, all morph o logica ll y normal pigmented G418-resistan t E1 A 
transfectants fa il ed to grow in the absence of TPA (Fig 1V). T he 
El A-transduced amelanotic melanocytes grew autonomously, 
~·ithout TPA , with an acce le rated growth rate of 1.3 d population 
doubling time against 3.2 d of the pSVneo controlmelanocytes that 
required the prescnce of TPA (Fig 1V; compare pSVnco with 
amelanotic NTdl598/1 and dI799N /2). Although before becoming 
confluent 3melanotic m e lanocytes transduced with the mutant 
NTdls98 (p60 +, p105 + , plOT'· , p300- ), or the-wild type E1A 
construct d l799N (p60 ·'· , p10s ,plOT'· , p300 +) had comparab le 
phenotypes and similar growth kinetics, at conAuency o nly the 
amelan otic d l799N (p60 +, pl05 + , p107 + , p300 +)-transduced 
c lo nes readily detached from the cu lture surface and died . T his 
lTlorta li ty might be attributable to the extremely high levels of E1 A 
protein expressed in these cells (see below) , which in tum can ca use 
apoptosis in the presence of w ild-type p53 (White, 1993) (see 
DisCIIssio/l). 
The transduced melanocytes, pigmented o r ame lanotic, regard-
less of the type of E1 A construct used to transfect them, did not 
g row as tumors in syngeneic mice, in agreement w ith our prev ious 
results with w ild-type El A (Dotto ci nl, 1989). Melanocytes 
transformed with mutant NTdl598 (p60 +, pl05 + , p107 + , p300 - ), 
like those transformed with wi ld-type ElA, grew as tumors w he n 
injected into nude mice. 
Downregulatioll of Several Melanocyte-Specific Proteins 
Correlates Positively with E1A Levels Loss of l11elanocytic 
functions was contingent o n high levels of E1 A, as confirmed by 
western imm unoblotting, and was associated with reductions in 
several melanogenic efFector proteins, such as tyrosinase, TI~l , 
and Pmel 17, but not TRP2 (Fig 2A,B). Tyrosinase, the key 
en zyme of melanogenes is, and Pmel 17 were absent frol11 all 
amelanot ic tralls[ormants , whereas residua l amounts of TRPl 
remained in the amelanotic transfectants that expressed only low 
levels of E1 A (Fig 2A; TRPl, NTd l598/2, and NTd I598 /3 ). Tn 
each case, westcrn immunoblotting revealed the expected molec-
u lar size of the immun o react ive proteins, w hjch included the newly 
synthesized - 56-kDa peptide backbone as well as partially and 
fu lly glycosylated forms of tyros in ase (70-75 kDa), processed 
TRPl/gp75 (70-80 kDa), and Pmcl 17 (90 kDa) (Fig 2A). In 
contrast, TRP2 was expressed in melanotic and amelanotic Lines 
(Fig 2B) . Antibodies to TRP2, known to precipitate a protein with 
dopachromc tautomerase activity (Tsukamoto ci nl, 1992), recog-
nized the expected 75-kDa species in both pigmented and amela-
notic melanocyte lin es and not in the NII-J 3T3 fibrobhlsts that ha d 
been ch osen as the nonmclanocytic negative-control ce ll s. Slower 
migrating aTRP2 immuno reactive proteins, however, - 110 kDa 
in size, were detected not on ly in the m e lan ocyte lines but also in 
the fibroblast Jjn e (Fig 2B). T he 11 O-kDa aTRP2-reactive bands 
were observed in mouse m e lanocyte lines also by o ther investiga-
tors (Orlow el (fl, 1995) and might represent an alternative form of 
T R.P2. As before (Fig 2A), rebl otting of the m embrane shown in 
Fig 2B with an ti-tyrosinasc and anti-TRP1 antibodies revealed 
hig hly reactive bands o nl y in the pigmented lines. None of the three 
am elanotic lines, including NIH 3T3 fibrob lasts, expressed tyrosi-
nase, and TRPl was detected at low levels o nl y in the amelanotic 
NTdl598/1 (p60 +, p105 + , plOT'· , p300 - ) and not the amelanotic 
dl799N12 (p60 ·'· , pI 05 '. , plOT" , p300 +) line or the N[H 3T3 
fib roblasts (data not shown) . 
By western immunoblotting of whole-cell extracts, abundanr 
El A protein w as found in the amelanotic dl799N (p60+ , pI 05 + , 
pI 07 + , p300 +)-transformed melanocytes , clone 2 (dI799NI2), and 
albeit at lower levels, tbe li kewise amelanotic NTdl598 (p60 +, 
1'105 + , pI 07 + , p300 - )-transformed melanocyte clones; no ElA 
product was detected in transfectants of normal phenotype, al-
though these ce lls were neomycin-resistant (Fig 2A; dl 922/1, 
dl922/2, dl799N/l, and dI799N/s). In each of the la tter, only 
minute amounts of E1A were fo un d after subjectin g a relatively 
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Figure 1. Phenotype of EtA transfectants. A. color of cell pellets : 
I representative clones . fi'om left to right. of pSVneo, NTd18 14, dI92211, 
d1799N / l, NTdI598 /2, and dl799N12 transtectants . T he numbers after the 
!lashes d esignate individual clones; constru ct d l922/ 947 is referred to as 
d1922 . B, phase-con trast photomicrographs of the melanotic pSV neo-
control transfectcd cells (II) and the two amelanotic d1799NI2- (b) and 
NT dI598 / 1-tr'1J1sfected clones (c) (magnification X 330) . C, relevant lI ltra-
muctura l detai ls of the melanotic NTdI814- (II) '1I1d am elanotic NTd1598/ 
I·tra n sfeeted clones (II). SCllle Ilnl's. 0. 2 /Lin . D . growth kinetics of t ransfec-
lants in the presence of800 /Lg/ ml G4 18 in medium w ith (0 ) o r w ithout (-) 
TPA. Each v<l lue is th l! average of dupli cate wells. T he standard e rror 
between duplic<lre we ll s ranged between 2 <lnd 14%. 
large amoun t of ce ll extract prote in (1 m g) to immunoprecipitation 
with anti- E1A antibodies (Fig 2Q. 
As exp ected on the basis of the immunoblotting data, no 
tyrosinase activity was detectable in the amelanotic NTdlS9S/ l 
(p60 + , plOS +, 1'107 + , p300 - )- and d l799N12 (p60 + , p105 +, 
REPR.ESSION OF M I IN TRANSFORMED M ELANOCYTES 1269 
pigm ent ed amelanotic 
pigmented amclanotic 
Figure 2 . Levels of EtA protein inversely correlate with sOlne 
Inelanocytc-spccific proteins. A, sllccessive western inl 111unoblots with 
antibodies against El A (El A) , tyros inase (Tyr 'ase), T IU) l . and Pmei 17 
antibodies . as described under MIlTe/ill ls 111111 Methods. Cells were lysed. and 
- 60 /Lg of protein fro m each sample was separated in S% polyacrylamide 
gels. transferred to po lyvinylidcnc difluoridc m cmbranes, and successive ly 
blo tted with the monoclonal an ti-E t A antibo dy (1 fJ.g / ml) o r antiserum 
(1:1000) for 1 h in the cold. in the order presented from top to bottom . 
Positions of prestaincd high m olecul ar size markers (Bio-Rad LaboratOlies) 
are givcn o n the left in kiloda ltons accord ing to the manufacturer' s size 
dctcrtninations . T ile 111arkcrs used were 111)'osin , f3-ga lac tosidase, bovine 
serum albumin. and ovalbumin . B. anti-TR .. P2 western imnlllnoblot of 
prote ins from the melanocyte transfecta nts and N lI-I 3T3 fibro blast" (neg-
ative con trol). C , immunoprecipitatio n of resid ual E1 A prote in fro m 
m elonotic t ransfcctants. One milligram of tota l protein waS used for each 
immunoprccipitatio n. IgGh marks the position of the heavy immunoglob-
ulin chain of the m o noclonal aE1A an tibody rcactive with thc secondary 
l-/IU>-linked antibody used in th e enhanced chemiluminesccnce dctection 
systclll.D. tyros inase activity. Tyrosina se activity was ll1CaSl1rcd a u dupli-
cate cell ex tracts during a 20-min incubation at 37"C using the Pomerantz 
assay as dcsclibcd (Halaban el 11/, 1983). Values represent microunics per mg 
of extrac t prote in . and the bars rl!present the standa rd error between 
dup li cates. 
plOT", p300 )-transduced melanocytes, compared with the nor-
mal activ ity in the melanotic trallSfectants (Fig 2D) . 
Melanocyte Gene Expression Is Downregulated in Antela-
notic TranfOrluants We investigated w hether extinction of 
melanocyte- specific proteins in amelanotic cells was attributable to 
downregul ation of the respective mRNAs. Levels of gene tran-
scripts were measured by quantitative RT-PC R , using pSVneo 
transduced melanocytes and NIH 3T3 fibroblasts as positive and 
negative controls (Fig 3) . As dem onstrated in Fig 3A, ml~As for 
tyrosinase and PED were undetectable in the two E1A- transduced 
amelanotic melanocyte lines, w hereas little Pmcl 17 product could 
be amplified from these cells and none fi'01l1 NIH 3T3 fibro blasts . 
Like the TRPl protein levels, the mRNA levels for TRPl corre-
lated inversely with E t A expression , because ampli fied RT-PCR 
products were present in the NTdlS9S/ l (p60 + , p1 05 + , p107 + , 
p300 - )-but not the dl799 N / 2 (p60 + , p105 -1 , p107 + , p300+)-
transfo rmed melanocytes. Likewise, corre lating with the western 
blotting data on protein products, express ion of mRNA for TlU)2 
(dopachrome tautomerase) was similar among the melan otic pSV-
nco-transduced contro l melan ocytes, amelanotic melan ocytes 
transformed by d l799N (p60 + , p1 05 + , p107+ , p300 +) or NTdI59S-
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Figure 3_ Downregulation of key melanocytic gene transcripts in 
amelanotic transformed mclanocytes_ A . R T-PCR analysis of gcnes 
cncodillg products specific for mclanocytes as compared with f3-:lctin. B, 
expressio n of the transcription factor Mi . Prinlcr pairs, the Natio nal Center 
fo r Biotechnology In formation accession numbers from which the se-
quellces wcre derived, and the sizes of the amplified products arc as 
described in Table II. All amplified products are of the expected size. 
E1A constructs , suggesting that TRP2 mRNA expression is not 
controlled sole ly by Mi . As expected, TIU)2 message was not 
detected in the NIl-I 3T3 nega tive-control cell s. 
T he RT-PC R products de rived from the pSVneo transfectants 
were sequenced and sh own to represent the segment of intended 
amplification, supporting th e assumption that the assay fa ithfu lly 
reAected the exp ress ion of particular, intended transcripts. 
Microphthalmia Is Repressed in Amelanotic Melanocytes 
To shed light on the mechanism of downregulation of melanogenic 
cffector genes in m elanocytes, w e examined the expression of Mi , 
a critical transcription £1ctor in control of pigmentation (Shibahara 
ef aI, 1991; Lowings cf aI, 1992; Yasumoto ef aI, 1994; Yavuzer el aI, 
1995) . R T-PCR analysis showed that no Mi gene transcripts were 
present in the am elanotic E1A transfectants (Fig 3B) . Simi larly, Mi 
produc ts were not fo und in the amelanotic ras and lI ell transfor-
mants o r in an am elanotic va riant of C lo udman S91 mouse 
melanoma cells (Fig 3). In contrast, B16 mou se me lanom a cells 
expressed Mi mRNA at levels simi.lar to those of no rmal melano-
cytes, despite the cell s havin g been am elanotic at the time of 
harvest (Fig 3B). 
O ur analysis of melanocyte gene expression was ex tended to the 
likewise am elanotic bFGF-cD NA transformants (Dotto e/ aI, 1988). 
Agaill , the proteins tyrosin ase, TRP1, TRP2, and PED w ere absent 
(Fig 4A) ; the mRNAs for tyrosinase, PED , TRP2, and Pmel 17 
were unde tectable o r extremely low, and those for TRPl were 
redu ccd _ Mi gene transcI;pts becam e extinct (Fig 4B). Tn contrast, 
the mJlNA for Met, the receptor for H epatocyte Growth Factor/ 
Scatter Factor, was fo und at levels similar to the housekeeping gene 
g lyce raldehyde-3-phosphate deh ydrogenasc_ For unknown rea-
sons, Kit, the receptor for mast cell g rowth factor, was downregu-
latcd in thc parental melanocyte line as weU as in the bFGF-
transdu ced cells (Fig 4B). 
DISCUSSION 
It is generally agreed that vira l oncogenes, inc ludiJl g E1 A , exert 
the ir e ffect on cell prolife ration and differentiation by binding, and 
thus inactivating, a set of regu latory prote ins, notably those belong-
ing to the retinobl as toma family of growth suppressors_ By seques-
tering those regulatory proteins, the vira l oncoproteins disrupt the 
growth inhibi tory E2F-pRb and E2F-pl07 complexes, thereby 
leading to liberation of transcriptionally active E2F species (for 
review, see N evins, 1993). Free E2Fl re leases growth constraints 
by inducing cells in to DNA synthesis in the absence of external 
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Figurc 4. Extinction of melanocytc-specific gcnc products in 
bFGF-transduccd mclanocytes. A, western il11munoblots, with antibod-
ies against tyrosinasc (Tyr), TRP1, TP' .. P2. and PED, of whole ce ll Iysa tes 
[rom mouse melanocytes transduced with pSVnco (1) or bFGF cDNA (2). 
B, R. T-PCR. ana lyses of total RNA from pSVnco (1 ) and bFGF (2) 
tr;l I1SforInants , lI sin g appropriate pril11CrS for Tn el~lnocytc-specific gene 
transcripts Tyr, PED , TR.P1, T RP2 , and pMel 17 as compared with f3 -actin 
(top panel); and Mi , M.ET, and KIT compared with mOllse glyceraldehyde-
3-phosphatc dehydrogenast! (G3PDH) (bottom panel). Size of amplified 
products :1I:e as described in Table II. As in Fig 3, :111 amplified products are 
of the expected size. 
stimulation (Nevins, 1993; Kowalik el aI, 1995). Recently, E2F was 
also implicated in regulating muscle differen tiation, as reA ected by 
cho ice of binding partner. 10m example , E2F-pl07 complexes were 
o bserved in undifferentiated ce.lls, w hereas E2 F-p:l 30 complexes 
predominated during differentiation. Other changes were m ani-
fested in altered phosphorylation and transcriptional activities (Shin 
etal, 1995). 
Because in m elan ocytes E1A not only confers the tumorigenic 
phenotype but also abrogates m e lanocyte-specific gene expression , 
we used dele tion mutants that w ere unable to bind particular 
E1 A-binding proteins to dete rmine which of the known E1A-
binding partners participate in maintaining the differentiated phe-
notype_ Furthermore, we investiga ted the mol ecular basis for 
dediffe rentiation and tumorigencsis. T he results suggest that in 
m elanocytes p300 binding is not required for E1 A-m ediated tumor-
igenesis, extinction of diffe rentiated fun ctions, and acquisition of 
independence from growth factors. The N T dl 598 (p60 + , p105 +, 
plOT", p300 - ) E1 A mutant, whi ch no longer binds p300, induced 
the amelanotic phenotype the same as the dl799N (p60 + , p10S +, 
p1 07+ , p300+) E1A wild-type construct, and the cells grew as 
tumo rs in nude mice . Our findi.ngs in this respect are similar to 
those of Boulukos and Ziff (1993), who demonstrated with rat 
pheochromocytom a (PC12) cclls, the neural-crest origin of which 
is shared w ith m elanocytes, that E1 A-mediated abrogation of the 
ne uronal phen otype and disruption of g rowth facto r responsiveness 
co uld be ach.ieved without seq uestration inactivation of p300. 
It is not clear why E1A prote in was extremely scarce in the 
G418-rcsistant clones transduced with N Tdl814 (p60 - . plOS - , 
pl07 + , p300- ) or dl9221947 (p60 - , p10S - , plOT, p300+). The 
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failure to achieve high E1 A expression with NTdl814 (p60 - , 
plO S - , P 1 07 + , p300 - ), a variant that does not bind the retinoblas-
toma gene product (Rb)-relatcd protein pJ07, as well as our 
inability to introduce p105 Rb or p107 mammalian expression 
vectors into E1A transformants stably (data not shown), has kept us 
from determining directly and unequivocally whether sequestration 
of pI 07 or p 105 Rb or both p.lays a role in mc.lanocytc proliferation 
and/ or differentiation. It is possible that these two proteins are 
critical £or the transformed 3melanotic phenotype, because mela-
nocytes tnnsfected with SV40 large T antigen, which binds pl05 
Rb and p107 in other cell types, undergo phenotypic changes 
similar to those observed in E1A transfectants (Larue 1'1 ai, 1993; 
Orlow et ai, 1995). 
Our analysis revea ls that ex pression of severaJ melanocyte-
specific key genes was suppressed or downregulated by EtA, bFGF, 
and the dominmltly acting oncogenes rns and IIC11 , possibly because 
of suppression of Mi. The downregulation ofmRNAs for PED and 
Pmel 17 suggests that the respective genes, like tyrosinase and 
TRPI (Bentley cI ai, 1994; Yavu zer ef ai, 1995) , are also controlled 
by Mi. T he sensitivity of response to reductions in Mi , however, 
differed among the four genes, with tyrosinase and PED being 
affected c onsiderably more so than Pm e) 17 and TRP1 , suggesting 
that other transcription f;l c tors participate in the expression of the 
latter nNo. TRJl2 expression , on the other hand , was independent 
of Mi. Recent analysis of TR.P2 genomic DNA segments that 
encode the 5' -promoter regions rcvealcd dissimilarities with the 
tyrosinase and T RPl enhan ccr/ promoter scquences (Shibahara ef 
ai, 1991). The TRP2 enhancer segment docs not contain the 
11 -base pair M-box found in tyrosinase and TRPl or the hcx<1mer 
core seq Llence CACGTG, specifica ll y rccognized b y the Mi tran-
scription fa ctor (Tsukamoto ef ai, 1992). These data , together with 
our findings on the transcriptional repression of Mi in rns and II CII , 
in transformed melanocytes, and in the spontaneo usly amelanotic 
J C)oudrna n S9 '1 m elan oma cells, strongly suggest that downregula-
tion of Mi is a key evcnt in oncogene- mediated suppression of 
differen tiation in melanocytes. Furthermore , the rccent discovery of 
mutations in microphthalmia associated transcription f;l ctor, the 
human hOl11olog of Mi, and PAX3 (cncoding a protein with a 
highly conserv ed transcription control sequence invol ved in regu-
lating elTI bryonic developmcnt) in Waardenburg's syndrome (an 
auditory / pigme ntary disorder) (Arias, 1993; Hoth ef ai, 1993 ; 
Tassabe hji ef ai , 1993; Baldwin et ai , '1994; Delezoide and Veke-
mans, 1994; Picrpont cl ai, 1994) provides support for the noti on 
tha t these tran scription factors control the development of mela-
nocytes in early embryogenesis. 
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